暂无分享,去创建一个
Sepp Hochreiter | Günter Klambauer | Andreas Mayr | Thomas Unterthiner | S. Hochreiter | Thomas Unterthiner | G. Klambauer | Andreas Mayr
[1] L. Kier. Molecular Orbital Theory In Drug Research , 1971 .
[2] Rich Caruana,et al. Multitask Learning , 1998, Encyclopedia of Machine Learning and Data Mining.
[3] Shu-Kun Lin. Pharmacophore Perception, Development and Use in Drug Design. Edited by Osman F. Güner , 2000 .
[4] Darren V. S. Green,et al. Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination , 2001, J. Chem. Inf. Comput. Sci..
[5] Jens Sadowski,et al. Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..
[6] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[7] Xiaoyang Xia,et al. Classification of kinase inhibitors using a Bayesian model. , 2004, Journal of medicinal chemistry.
[8] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[9] J. Kazius,et al. Derivation and validation of toxicophores for mutagenicity prediction. , 2005, Journal of medicinal chemistry.
[10] Adam Yasgar,et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Bender,et al. In silico target fishing: Predicting biological targets from chemical structure , 2006 .
[12] I. Rusyn,et al. Genomic Profiling in Nuclear Receptor-Mediated Toxicity , 2007, Toxicologic pathology.
[13] Andreas Bender,et al. Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics , 2008, J. Chem. Inf. Model..
[14] Weida Tong,et al. Mold2, Molecular Descriptors from 2D Structures for Chemoinformatics and Toxicoinformatics , 2008, J. Chem. Inf. Model..
[15] Geoffrey E. Hinton,et al. Rectified Linear Units Improve Restricted Boltzmann Machines , 2010, ICML.
[16] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[17] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[18] Robert C. Glen,et al. Classifying Molecules Using a Sparse Probabilistic Kernel Binary Classifier , 2011, J. Chem. Inf. Model..
[19] Yoshua Bengio,et al. Deep Sparse Rectifier Neural Networks , 2011, AISTATS.
[20] J. Arrowsmith. Trial watch: Phase III and submission failures: 2007–2010 , 2011, Nature Reviews Drug Discovery.
[21] P. Willett,et al. PHARMACOPHORE PERCEPTION , DEVELOPMENT , AND USE IN DRUG DESIGN , 2011 .
[22] Nitish Srivastava,et al. Improving neural networks by preventing co-adaptation of feature detectors , 2012, ArXiv.
[23] John B. O. Mitchell,et al. Predicting the mechanism of phospholipidosis , 2012, Journal of Cheminformatics.
[24] Geoffrey E. Hinton,et al. ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.
[25] Robert C. Glen,et al. Full “Laplacianised” posterior naive Bayesian algorithm , 2013, Journal of Cheminformatics.
[26] Pascal Vincent,et al. Representation Learning: A Review and New Perspectives , 2012, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[27] Dong-Sheng Cao,et al. ChemoPy: freely available python package for computational biology and chemoinformatics , 2013, Bioinform..
[28] Geoffrey Zweig,et al. Recent advances in deep learning for speech research at Microsoft , 2013, 2013 IEEE International Conference on Acoustics, Speech and Signal Processing.
[29] Yoshua Bengio,et al. Deep Learning of Representations: Looking Forward , 2013, SLSP.
[30] Nitish Srivastava,et al. Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..
[31] Navdeep Jaitly,et al. Multi-task Neural Networks for QSAR Predictions , 2014, ArXiv.
[32] Vijay S. Pande,et al. Massively Multitask Networks for Drug Discovery , 2015, ArXiv.
[33] Andreas Mayr,et al. Deep Learning as an Opportunity in Virtual Screening , 2015 .
[34] Bie M. P. Verbist,et al. Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project. , 2015, Drug discovery today.